Coeptis Therapeutics Holdings, Inc. Reports Voting Results from Annual Meeting
Coeptis Therapeutics Holdings, Inc. recently conducted its Annual Meeting of Stockholders on December 18, 2024. The meeting saw an active participation from shareholders who voted on various proposals as detailed in the definitive proxy statement filed with the Securities and Exchange Commission (SEC) on November 14, 2024. Out of the 41,118,593 shares of the Company’s […]
More Stories
Head to Head Survey: Integra LifeSciences (NASDAQ:IART) & Alpha Tau Medical (NASDAQ:DRTS)
Alpha Tau Medical (NASDAQ:DRTS – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both small-cap medical...
Zoetis Inc. (NYSE:ZTS) Receives Consensus Recommendation of “Buy” from Analysts
Zoetis Inc. (NYSE:ZTS – Get Free Report) has been assigned an average recommendation of “Buy” from the eleven ratings firms...
Reinsurance Group of America, Incorporated (NYSE:RGA) Receives Average Recommendation of “Moderate Buy” from Analysts
Reinsurance Group of America, Incorporated (NYSE:RGA – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by...
Analysts Set Health Catalyst, Inc. (NASDAQ:HCAT) Price Target at $11.79
Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) has received an average recommendation of “Moderate Buy” from the twelve analysts...
Genmab A/S (NASDAQ:GMAB) Receives $45.20 Average Price Target from Analysts
Shares of Genmab A/S (NASDAQ:GMAB – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the...
Brokerages Set Invesco Ltd. (NYSE:IVZ) Target Price at $18.63
Invesco Ltd. (NYSE:IVZ – Get Free Report) has received an average recommendation of “Hold” from the twelve research firms that...